IQVIA艾昆纬:2026年迈向可持续临床试验转型之路白皮书(英文版).pdf |
下载文档 |
资源简介
Clinical trials are a core component of advancing medical progress in a safe and ethical manner. As they involve complex manufacturing, a globalised supply chain and in-person monitoring, they generate a substantial quantity of emissions, of which IQVIA calculates at 2.0mn tCO2e in 2023. A balanced approach should be taken to optimise trial emissions whilst recognising that medicines prevent downstream carbon emissions through greater use of energy-intensive care. Despite a growing awareness
本文档仅能预览20页



